InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Christopher Mutz, a HEAD OF RARE DISEASE, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 11 open-market SEC Form 4 transactions: 0 purchases worth $0 and 11 sales worth $2.9M, reported from Nov 10, 23 to Mar 13, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 13, 26 | ANIPANI PHARMACEUTICALS INC | SELL | 3.2K | $71.64 | $227K |
| Mar 9, 26 | ANIPANI PHARMACEUTICALS INC | SELL | 3.6K | $74.18 | $267K |
| Mar 6, 26 | ANIPANI PHARMACEUTICALS INC | SELL | 2.1K | $74.22 | $157K |
| Mar 2, 26 | ANIPANI PHARMACEUTICALS INC | SELL | 417 | $74.00 | $31K |
| Feb 20, 26 | ANIPANI PHARMACEUTICALS INC | SELL | 5.3K | $78.02 | $415K |
| Feb 12, 26 | ANIPANI PHARMACEUTICALS INC | SELL | 7.0K | $76.55 | $538K |
| May 14, 25 | ANIPANI PHARMACEUTICALS INC | SELL | 4.0K | $60.45 | $242K |
| Nov 15, 24 | ANIPANI PHARMACEUTICALS INC | SELL | 6.5K | $57.70 | $375K |
| May 21, 24 | ANIPANI PHARMACEUTICALS INC | SELL | 2.0K | $61.61 | $123K |
| Mar 5, 24 | ANIPANI PHARMACEUTICALS INC | SELL | 5.0K | $66.00 | $330K |
| Nov 10, 23 | ANIPANI PHARMACEUTICALS INC | SELL | 3.0K | $52.47 | $157K |